Glycyrrhiza and Uncaria Hook contribute to protective effect of traditional Japanese medicine yokukansan against amyloid β oligomer-induced neuronal death

Journal of Ethnopharmacology

Volumn 149, Issue 1, 2013, Pages 360-370

  Kanno, Hitomi ^a   Kawakami, Zenji ^a   Iizuka, Seiichi ^a   Tabuchi, Masahiro ^a   Mizoguchi, Kazushige ^a   Ikarashi, Yasushi ^a   Kase, Yoshio ^a  

^a TSUMURA AND CO   (Japan)

Author keywords

Amyloid oligomer; Apoptosis; Cultured neuron; Glycyrrhiza; Hook; Uncaria; Yokukansan

Indexed keywords

AMYLOID BETA PROTEIN; CASPASE 3; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG; YOKUKANSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; ELECTRON MICROSCOPY; EMBRYO; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; GENE EXPRESSION; GLYCYRRHIZA; JAPANESE MEDICINE; MEMORY DISORDER; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; RAT; TRADITIONAL MEDICINE; UNCARIA;

ANIMALIA; GLYCYRRHIZA; MUS; MUS MUSCULUS; RATTUS; UNCARIA;

AMYLOID Β OLIGOMER; APOPTOSIS; CULTURED NEURON; GLYCYRRHIZA; UNCARIA HOOK; YOKUKANSAN;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DRUGS, CHINESE HERBAL; ENDOPLASMIC RETICULUM STRESS; ETHNOPHARMACOLOGY; GLYCYRRHIZA; MEDICINE, KAMPO; NEURONS; NEUROPROTECTIVE AGENTS; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY; UNCARIA;

EID: 84882267168     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.06.052     Document Type: Article

References (56)

1. 2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors Cell Calcium 47 2010 264 272
2. C. Chambon, N. Wegener, A. Gravius, and W. Danysz Behavioural and cellular effects of exogenous amyloid-beta peptides in rodents Behavioural Brain Research 225 2011 623 641
3. B.J. Cummings, and C.W. Cotman Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity Lancet 346 1995 1524 1528
4. K.N. Dahlgren, A.M. Manelli, W.B. Stine Jr.; L.K. Baker, G.A. Krafft, and M.J. LaDu Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability Journal of Biological Chemistry 277 2002 32046 32053
5. M. Fernandez, A.L. Gobartt, and M. Balana Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment BMC Neurology 10 2010 87
6. H. Fujiwara, S. Takayama, K. Iwasaki, M. Tabuchi, T. Yamaguchi, K. Sekiguchi, Y. Ikarashi, Y. Kudo, Y. Kase, H. Arai, and N. Yaegashi Yokukansan, a traditional Japanese medicine, ameliorates memory disturbance and abnormal social interaction with anti-aggregation effect of cerebral amyloid beta proteins in amyloid precursor protein transgenic mice Neuroscience 180 2011 305 313
7. Y. Hayashi, Y. Ishida, T. Inoue, M. Udagawa, K. Takeuchi, H. Yoshimuta, K. Kiue, Y. Ninomiya, J. Kawano, T. Sameshima, T. Kawahara, I. Goto, K. Shudo, S. Kurayama, J. Nakamura, K. Okahara, and Y. Mitsuyama Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice Progress in Neuro-Psychopharmacology and Biological Psychiatry 34 2010 541 545
8. T. Hiratsuka, S. Matsuzaki, S. Miyata, M. Kinoshita, K. Kakehi, S. Nishida, T. Katayama, and M. Tohyama Yokukansan inhibits neuronal death during ER stress by regulating the unfolded protein response PloS One 5 2010 e13280
9. J. Hitomi, T. Katayama, Y. Eguchi, T. Kudo, M. Taniguchi, Y. Koyama, T. Manabe, S. Yamagishi, Y. Bando, K. Imaizumi, Y. Tsujimoto, and M. Tohyama Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death Journal of Cell Biology 165 2004 347 356
10. M. Hoshi, M. Sato, S. Matsumoto, A. Noguchi, K. Yasutake, N. Yoshida, and K. Sato Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta Proceedings of the National Academy of Sciences of the United States of America 100 2003 6370 6375
11. http://www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm110212.htm, 2008
12. http://www.fda.gov/downloads/Drugs/DrugSafety/UCM300946.pdf, 2012.
13. K. Iwasaki, M. Maruyama, N. Tomita, K. Furukawa, M. Nemoto, H. Fujiwara, T. Seki, M. Fujii, M. Kodama, and H. Arai Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies Journal of Clinical Psychiatry 66 2005 1612 1613
14. K. Iwasaki, T. Satoh-Nakagawa, M. Maruyama, Y. Monma, M. Nemoto, N. Tomita, H. Tanji, H. Fujiwara, T. Seki, M. Fujii, H. Arai, and H. Sasaki A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients Journal of Clinical Psychiatry 66 2005 248 252
15. H. Kadowaki, H. Nishitoh, F. Urano, C. Sadamitsu, A. Matsuzawa, K. Takeda, H. Masutani, J. Yodoi, Y. Urano, T. Nagano, and H. Ichijo Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation Cell Death and Differentiation 12 2005 19 24
16. P. Kaur, S. Kaur, N. Kumar, B. Singh, and S. Kumar Evaluation of antigenotoxic activity of isoliquiritin apioside from Glycyrrhiza glabra L Toxicology in Vitro 23 2009 680 686
17. Z. Kawakami, Y. Ikarashi, and Y. Kase Glycyrrhizin and its metabolite 18 beta-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes European Journal of Pharmacology 626 2010 154 158
18. Z. Kawakami, Y. Ikarashi, and Y. Kase Isoliquiritigenin is a novel NMDA receptor antagonist in kampo medicine yokukansan Cellular and Molecular Neurobiology 31 2011 1203 1212
19. Z. Kawakami, H. Kanno, Y. Ikarashi, and Y. Kase Yokukansan, a kampo medicine, protects against glutamate cytotoxicity due to oxidative stress in PC12 cells Journal of Ethnopharmacology 134 2011 74 81
20. T.I. Kim, Y.K. Lee, S.G. Park, I.S. Choi, J.O. Ban, H.K. Park, S.-Y. Nam, Y.W. Yun, S.B. Han, K.W. Oh, and J.T. Hong l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: Reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways Free Radical Biology and Medicine 47 2009 1601 1610
21. M. Kobayashi, T. Sato, A. Sato, and T. Imamura Oldest-old dementia in a Japanese memory clinic Brain and Nerve 61 2009 972 978 (in Japanese)
22. L. Kreplak, and U. Aebi From the polymorphism of amyloid fibrils to their assembly mechanism and cytotoxicity Advances in Protein Chemistry 73 2006 217 233
23. Y. Lee do, K.S. Lee, H.J. Lee, H. Kim do, Y.H. Noh, K. Yu, H.Y. Jung, S.H. Lee, J.Y. Lee, Y.C. Youn, Y. Jeong, D.K. Kim, W.B. Lee, and S.S Kim Activation of PERK signaling attenuates Abeta-mediated ER stress PloS One 5 2010 e10489
24. D. Li, Z. Wang, H. Chen, J. Wang, Q. Zheng, J. Shang, and J. Li Isoliquiritigenin induces monocytic differentiation of HL-60 cells Free Radical Biology and Medicine 46 2009 731 736
25. J.H. Liang, J. Du, L.D. Xu, T. Jiang, S. Hao, J. Bi, and B. Jiang Catalpol protects primary cultured cortical neurons induced by Abeta(1-42) through a mitochondrial-dependent caspase pathway Neurochemistry International 55 2009 741 746
26. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, L. Sue, T. Beach, J.H. Kurth, R.E. Rydel, and J. Rogers Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease American Journal of Pathology 155 1999 853 862
27. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, K. Beyreuther, A.I. Bush, and C.L. Masters Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Annals of Neurology 46 1999 860 866
28. M.S. Mega, J.L. Cummings, T. Fiorello, and J. Gornbein The spectrum of behavioral changes in Alzheimer's disease Neurology 46 1996 130 135
29. A. Monji, M. Takita, T. Samejima, T. Takaishi, K. Hashimoto, H. Matsunaga, M. Oda, Y. Sumida, Y. Mizoguchi, T. Kato, H. Horikawa, and S. Kanba Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease Progress in Neuro-Psychopharmacology and Biological Psychiatry 33 2009 308 311
30. T. Nakagawa, H. Zhu, N. Morishima, E. Li, J. Xu, B.A. Yankner, and J. Yuan Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta Nature 403 2000 98 103
31. S. Nakamura, N. Murayama, T. Noshita, H. Annoura, and T. Ohno Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide Brain Research 912 2001 128 136
32. J. Naslund, V. Haroutunian, R. Mohs, K.L. Davis, P. Davies, P. Greengard, and J.D. Buxbaum Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline Journal of the American Medical Association 283 2000 1571 1577
33. L. Ou, Y. Wu, C. Ip, X. Meng, Y.C. Hsu, and M.M. Ip Apoptosis induced by t10,c12-conjugated linoleic acid is mediated by an atypical endoplasmic reticulum stress response Journal of Lipid Research 49 2008 985 994
34. L. Parnetti, S. Amici, A. Lanari, and V. Gallai Pharmacological treatment of non-cognitive disturbances in dementia disorders Mechanisms of Ageing and Development 122 2001 2063 2069
35. C.J. Pike, D. Burdick, A.J. Walencewicz, C.G. Glabe, and C.W. Cotman Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state Journal of Neuroscience 13 1993 1676 1687
36. R. Resende, E. Ferreiro, C. Pereira, and C. Resende de Oliveira Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death Neuroscience 155 2008 725 737
37. H. Sakahira, M. Enari, and S. Nagata Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis Nature 391 1998 96 99
38. A.N. Santos, M. Ewers, L. Minthon, A. Simm, R.E. Silber, K. Blennow, D. Prvulovic, O. Hansson, and H. Hampel Amyloid-beta oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease Journal of Alzheimer's disease 29 2012 171 176
39. G. Seeger, U. Gartner, U. Ueberham, S. Rohn, and T. Arendt FAD-mutation of APP is associated with a loss of its synaptotrophic activity Neurobiology of Disease 35 2009 258 263
40. K. Sekiguchi, S. Imamura, T. Yamaguchi, M. Tabuchi, H. Kanno, K. Terawaki, Y. Kase, and Y. Ikarashi Effects of yokukansan and donepezil on learning disturbance and aggressiveness induced by intracerebroventricular injection of amyloid beta protein in mice Phytotherapy Research 25 2011 501 507
41. K. Sekiguchi, T. Yamaguchi, M. Tabuchi, Y. Ikarashi, and Y. Kase Effects of yokukansan, a traditional Japanese medicine, on aggressiveness induced by intracerebroventricular injection of amyloid beta protein into mice Phytotherapy Research 23 2009 1175 1181
42. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, C.M. Regan, D.M. Walsh, B.L. Sabatini, and D.J. Selkoe Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nature Medicine 14 2008 837 842
43. Y. Shimada, H. Goto, T. Itoh, I. Sakakibara, M. Kubo, H. Sasaki, and K. Terasawa Evaluation of the protective effects of alkaloids isolated from the hooks and stems of Uncaria sinensis on glutamate-induced neuronal death in cultured cerebellar granule cells from rats Journal of Pharmacy and Pharmacology 51 1999 715 722
44. M.S. Song, G. Rauw, G.B. Baker, and S. Kar Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation European Journal of Neuroscience 28 2008 1989 2002
45. J.H. Su, M. Zhao, A.J. Anderson, A. Srinivasan, and C.W. Cotman Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology Brain Research 898 2001 350 357
46. Y.X. Sun, Y. Tang, A.L. Wu, T. Liu, X.L. Dai, Q.S. Zheng, and Z.B. Wang Neuroprotective effect of liquiritin against focal cerebral ischemia/reperfusion in mice via its antioxidant and antiapoptosis properties Journal of Asian Natural Products Research 12 2010 1051 1060
47. M. Tabuchi, T. Yamaguchi, S. Iizuka, S. Imamura, Y. Ikarashi, and Y. Kase Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer's disease Journal of Ethnopharmacology 122 2009 157 162
48. R. Tarawneh, and J.E. Galvin Potential future neuroprotective therapies for neurodegenerative disorders and stroke Clinics in Geriatric Medicine 26 2010 125 147
49. M. Tateno, W. Ukai, T. Ono, S. Saito, E. Hashimoto, and T. Saito Neuroprotective effects of Yi-Gan San against beta amyloid-induced cytotoxicity on rat cortical neurons Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 2008 1704 1707
50. T. Tomiyama, S. Matsuyama, H. Iso, T. Umeda, H. Takuma, K. Ohnishi, K. Ishibashi, R. Teraoka, N. Sakama, T. Yamashita, K. Nishitsuji, K. Ito, H. Shimada, M.P. Lambert, W.L. Klein, and H. Mori A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo Journal of Neuroscience 30 2010 4845 4856
51. M. Townsend, G.M. Shankar, T. Mehta, D.M. Walsh, and D.J. Selkoe Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers The Journal of physiology 572 2006 477 492
52. M.Y. Um, J.Y. Ahn, S. Kim, M.K. Kim, and T.Y. Ha Sesaminol glucosides protect beta-amyloid peptide-induced cognitive deficits in mice Biological and Pharmaceutical Bulletin 32 2009 1516 1520
53. P.S. Wang, S. Schneeweiss, J. Avorn, M.A. Fischer, H. Mogun, D.H. Solomon, and M.A. Brookhart Risk of death in elderly users of conventional vs. atypical antipsychotic medications New England Journal of Medicine 353 2005 2335 2341
54. S.B. Yim, S.E. Park, and C.S. Lee Protective effect of glycyrrhizin on 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells Journal of Pharmacology and Experimental Therapeutics 321 2007 816 822
55. O. Yokota, K. Sasaki, Y. Fujisawa, J. Takahashi, S. Terada, T. Ishihara, H. Nakashima, A. Kugo, T. Ata, H. Ishizu, and S. Kuroda Frequency of early and late-onset dementias in a Japanese memory disorders clinic European Journal of Neurology 12 2005 782 790
56. M.S. Yu, K.C. Suen, N.S. Kwok, K.F. So, J. Hugon, and R.C. Chang Beta-amyloid peptides induces neuronal apoptosis via a mechanism independent of unfolded protein responses Apoptosis 11 2006 687 700